Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
TERMINATED
NCT00893516
PHASE2
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Sponsor: Emergent BioSolutions
View on ClinicalTrials.gov
Summary
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
Official title: A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2007-05
Completion Date
2008-12
Last Updated
2026-10-07
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
CHOP + CD4
DRUG
CHOP